| Literature DB >> 30587069 |
Masashi Okubo1, Tasuku Matsuyama2, Koichiro Gibo3, Sho Komukai4, Junichi Izawa5,6, Kosuke Kiyohara7, Chika Nishiyama8, Takeyuki Kiguchi9, Clifton W Callaway1, Taku Iwami9, Tetsuhisa Kitamura10.
Abstract
Background Layperson cardiopulmonary resuscitation ( CPR ) is a crucial intervention for patients with out-of-hospital cardiac arrest ( OHCA ). Although a sex disparity in receiving layperson CPR (ie, female patients were less likely to receive layperson CPR ) has been reported in adults, there are few data in the pediatric population, and we therefore investigated sex differences in receiving layperson CPR in pediatric patients with OHCA . Methods and Results From the All-Japan Utstein Registry, a prospective, nationwide, population-based OHCA database, we included pediatric patients (≤17 years) with layperson-witnessed OHCA from 2005 through 2015. The primary outcome was receiving layperson CPR . Patient sex was the main exposure. We fitted multivariable logistic regression models to examine associations between patient sex and receiving layperson CPR . We included a total of 4525 pediatric patients with layperson-witnessed OHCA in this study, 1669 (36.9%) of whom were female. Female patients received layperson CPR more often than male patients (831/1669 [49.8%] versus 1336/2856 [46.8%], P=0.05). After adjustment for age, time of day of arrest, year, witnesses persons, and dispatcher CPR instruction, the sex difference in receiving layperson CPR was not significant (adjusted odds ratio for female subjects 1.14, 95% CI, 0.996-1.31). Conclusions In a pediatric population, female patients with layperson-witnessed OHCA received layperson CPR more often than male patients. After adjustment for covariates, there was no significant association between patient sex and receiving layperson CPR .Entities:
Keywords: cardiac arrest; cardiopulmonary resuscitation; gender differences; pediatric
Mesh:
Year: 2019 PMID: 30587069 PMCID: PMC6405730 DOI: 10.1161/JAHA.118.010324
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Study participant flowchart. CPR indicates cardiopulmonary resuscitation; EMS, emergency medical services.
Patient Characteristics By Sex
| Female (n=1669) | Male (n=2856) |
| |
|---|---|---|---|
| Age, y, median (IQR) | 3 (0‐12) | 7 (1‐15) | <0.001 |
| Age category, n (%) | |||
| Infants (0 y) | 497 (29.8) | 634 (22.2) | <0.001 |
| Children (1‐11 y) | 749 (44.9) | 1107 (38.8) | |
| Adolescents (12‐17 y) | 423 (25.3) | 1115 (39.0) | |
| Characteristics of witnesses, n (%) | |||
| Family | 1144 (68.5) | 1587 (55.6) | <0.001 |
| Friends | 76 (4.6) | 317 (11.1) | |
| Colleagues | 3 (0.2) | 43 (1.5) | |
| Passersby | 132 (7.9) | 287 (10.0) | |
| Others | 314 (18.8) | 622 (21.8) | |
| Season, n (%) | |||
| Spring | 415 (24.9) | 704 (24.6) | 0.002 |
| Summer | 364 (21.8) | 759 (26.6) | |
| Autumn | 431 (25.8) | 657 (23.0) | |
| Winter | 459 (27.5) | 736 (25.8) | |
| Time of day, n (%) | |||
| Daytime (9:00 | 691 (41.4) | 1247 (43.7) | 0.138 |
| Night (5:00 | 978 (58.6) | 1609 (56.3) | |
| First documented rhythm, n (%) | |||
| VF/pulseless VT | 187 (11.2) | 431 (15.1) | <0.001 |
| PEA | 514 (30.8) | 772 (27.0) | |
| Asystole | 968 (58.0) | 1653 (57.9) | |
| Etiology, n (%) | |||
| Cardiac etiology | 611 (36.6) | 956 (33.5) | 0.032 |
| Noncardiac etiology | 1058 (63.4) | 1900 (66.5) | |
| Dispatcher CPR instruction, n (%) | 699 (42.3) | 1104 (39.3) | 0.050 |
| Epinephrine, n (%) | 49 (3.0) | 121 (4.4) | 0.094 |
| Advanced airway management, n (%) | 1317 (78.7) | 2276 (79.7) | 0.436 |
| EMS resuscitation time, min, median (IQR) | |||
| EMS response time (call to contact with patient) | 8 (6‐10) | 8 (6‐10) | 0.087 |
| Hospital arrival time (call to hospital arrival) | 28 (22‐37) | 28 (22‐37) | 0.418 |
CPR indicates cardiopulmonary resuscitation; EMS, emergency medical services; IQR, interquartile range; PEA, pulseless electrical activity; VF, ventricular fibrillation; VT, ventricular tachycardia.
Comparison between the 2 groups were evaluated with Wilcoxon rank‐sum test for continuous variables and chi‐squared test for categorical variables.
Difference in Receiving Layperson CPR by Patient Sex
| Overall Layperson‐Witnessed Arrest | Arrest Witnessed by Family | Arrest Witnessed by Nonfamily | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Female (n=1669) | Male (n=2856) |
| Female (n=1144) | Male (n=1587) |
| Female (n=525) | Male (n=1269) |
| |
| Layperson CPR, n (%) | 831 (49.8) | 1336 (46.8) | 0.050 | 600 (52.4) | 745 (46.9) | 0.005 | 231 (44.0) | 591 (46.6) | 0.320 |
| Types of CPR | |||||||||
| Chest compression–only CPR | 468 (28.0) | 746 (26.1) | 0.144 | 352 (30.8) | 434 (27.3) | 0.018 | 116 (22.1) | 312 (24.6) | 0.492 |
| Conventional CPR | 363 (21.7) | 590 (20.7) | 248 (21.7) | 311 (19.6) | 115 (21.9) | 279 (22.0) | |||
| Public‐access AED use | 31 (1.9) | 105 (3.7) | 0.001 | 4 (0.3) | 5 (0.3) | 0.876 | 27 (5.1) | 100 (7.9) | 0.040 |
AED indicates automated external defibrillator; CPR, cardiopulmonary resuscitation.
Comparison between the 2 groups was evaluated with chi‐squared test.
Figure 2Association between receiving layperson cardiopulmonary resuscitation and sex of the patient, stratified by age group. Overall layperson‐witnessed arrest (A), arrest witnessed by family (B), and arrest witnessed by nonfamily (C). *Adjusted for age group, time of day of arrest, year, witnesses, and dispatcher CPR instruction. †Adjusted for age group, time of day of arrest, year, and dispatcher CPR instruction. OR indicates odds ratio.
Sex Differences in Secondary Outcomes After OHCA, Stratified by Age Group
| Overall Layperson‐Witnessed Arrest | Arrest Witnessed by Family | Arrest Witnessed by Nonfamily | ||||
|---|---|---|---|---|---|---|
| Female (n=1669) | Male (n=2856) | Female (n=1144) | Male (n=1587) | Female (n=525) | Male (n=1269) | |
| All age groups | ||||||
| 1‐mo survival, n (%) | 315 (18.9) | 507 (17.8) | 215 (18.8) | 303 (19.1) | 100 (19.0) | 204 (16.1) |
| Crude OR (95% CI) | 1.08 (0.92‐1.26) | Reference | 0.98 (0.81‐1.19) | Reference | 1.23 (0.94‐1.60) | Reference |
| Adjusted OR (95% CI) | 1.19 (0.997‐1.42) | Reference | 1.05 (0.85‐1.30) | Reference | 1.53 (1.11‐2.12) | Reference |
| Favorable functional status at 1 mo (CPC 1 or 2), n (%) | 120 (7.2) | 230 (8.1) | 60 (5.2) | 102 (6.4) | 60 (11.4) | 128 (10.1) |
| Crude OR (95% CI) | 0.89 (0.70‐1.11) | Reference | 0.81 (0.58‐1.12) | Reference | 1.15 (0.83‐1.59) | Reference |
| Adjusted OR (95% CI) | 1.29 (0.98‐1.71) | Reference | 0.96 (0.67‐1.39) | Reference | 2.02 (1.30‐3.14) | Reference |
| Infants (0 y) | ||||||
| 1‐mo survival, n (%) | 93 (18.7) | 104 (16.4) | 82 (19.7) | 89 (17.2) | 11 (13.8) | 15 (12.7) |
| Crude OR (95% CI) | 1.17 (0.86‐1.60) | Reference | 1.17 (0.84‐1.64) | Reference | 1.10 (0.48‐2.53) | Reference |
| Adjusted OR (95% CI) | 1.17 (0.84‐1.63) | Reference | 1.13 (0.80‐1.59) | Reference | 0.85 (0.31‐2.36) | Reference |
| Favorable functional status at 1 mo (CPC 1 or 2), n (%) | 18 (3.6) | 32 (5.0) | 15 (3.6) | 28 (5.4) | 3 (3.8) | 4 (3.4) |
| Crude OR (95% CI) | 0.71 (0.39‐1.28) | Reference | 0.65 (0.34‐1.23) | Reference | 1.11 (0.24‐5.10) | Reference |
| Adjusted OR (95% CI) | 0.79 (0.43‐1.47) | Reference | 0.65 (0.34‐1.25) | Reference | 1.71 (0.19‐15.15) | Reference |
| Children (1‐11 y) | ||||||
| 1‐mo survival, n (%) | 119 (15.9) | 176 (15.9) | 94 (16.2) | 132 (17.3) | 25 (14.8) | 44 (12.8) |
| Crude OR (95% CI) | 1.00 (0.78‐1.29) | Reference | 0.93 (0.69‐1.24) | Reference | 1.18 (0.70‐2.01) | Reference |
| Adjusted OR (95% CI) | 1.02 (0.77‐1.34) | Reference | 0.97 (0.71‐1.34) | Reference | 1.04 (0.59‐1.86) | Reference |
| Favorable functional status at 1 mo (CPC 1 or 2), n (%) | 37 (4.9) | 44 (4.0) | 29 (5.0) | 30 (3.9) | 8 (4.7) | 14 (4.1) |
| Crude OR (95% CI) | 1.26 (0.80‐1.96) | Reference | 1.29 (0.76‐2.17) | Reference | 1.17 (0.48‐2.85) | Reference |
| Adjusted OR (95% CI) | 1.36 (0.83‐2.24) | Reference | 1.39 (0.78‐2.45) | Reference | 0.78 (0.23‐2.66) | Reference |
| Adolescents (12‐17 y) | ||||||
| 1‐mo survival, n (%) | 103 (24.3) | 227 (20.4) | 39 (26.5) | 82 (26.6) | 64 (23.2) | 145 (18.0) |
| Crude OR (95% CI) | 1.26 (0.97‐1.64) | Reference | 1.00 (0.64‐1.55) | Reference | 1.38 (0.99‐1.92) | Reference |
| Adjusted OR (95% CI) | 1.62 (1.16‐2.27) | Reference | 1.08 (0.65‐1.81) | Reference | 2.18 (1.37‐3.48) | Reference |
| Favorable functional status at 1 mo (CPC 1 or 2), n (%) | 65 (15.4) | 154 (13.8) | 16 (11.0) | 44 (14.3) | 49 (17.8) | 110 (13.6) |
| Crude OR (95% CI) | 1.14 (0.83‐1.56) | Reference | 0.74 (0.40‐1.36) | Reference | 1.37 (0.95‐1.98) | Reference |
| Adjusted OR (95% CI) | 1.63 (1.07‐2.48) | Reference | 0.81 (0.38‐1.72) | Reference | 2.44 (1.43‐4.16) | Reference |
AED indicates automated external defibrillator; CPC, cerebral performance category; CPR, cardiopulmonary resuscitation; EMS, emergency medical services; OHCA, out‐of‐hospital cardiac arrest; OR, odds ratio.
Adjusted for age, public AED use, layperson CPR, dispatcher instruction, etiology of arrests, first documented rhythm, EMS response time.
Adjusted for public AED use, layperson CPR, dispatcher instruction, etiology of arrests, first documented rhythm, EMS response time.